The Comparative Study on the Efficacy and Safety of Single Acupoint and Matching Acupoints

Exclusion Criteria

• •1. To receive radiotherapy and chemotherapy
• •2. Gastrointestinal tumors
• •3. Patients with serious liver disease or abnormal hepatorenal function (Aspartate Aminotransferase, Alanine Aminotransferase , and Total Bilirubin are 3 times more than normal, blood urea nitrogen and Cr are 2 times more than normal)
• •4. Presence of cardiac pacemaker
• •5. Inflammatory skin reaction
• •6. Nausea and/or vomiting resulting from opioids or metabolic imbalance (electrolytic disturbances)
• •7. Patients unable to provide self-care or communication
• •8. Nausea and/or vomiting resulting from mechanical risk factors (i.e.,intestinal obstruction)
• •9. Patients with brain metastases or symptoms of intracranial hypertension
• •10. Nausea and/or vomiting resulting from other diseases(i.e.,sympathetic cervical dispositions, Meniere's syndrome)
• •11. Women in pregnant and lactating period
• •12. Refusal to sign informed consent, rejection of randomization into intervention groups.